CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory monitoring and ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help ...
Philips is integrating its cardiac ambulatory monitoring and diagnostic services within Epic’s Aura system. The partnership removes the need for providers and organizations to review and order patient ...
The US Food and Drug Administration (FDA) has cleared Philips’ SmartHeart AI, setting clinicians up with a tool to streamline cardiac magnetic resonance (MR) workflows. MR of the heart is viewed as ...
Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring The access to Philips technology within the ...
Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home With 2020 sales of USD 450 million, BioTelemetry adds a complete ...
June 17, 2026An accessible entry point brings full-powered Philips monitoring, frictionless measurement expansion and scalable connectivity to ...
Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands – Royal Philips ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results